Abstract PR10: Reprogramming myeloid cells in TME with pepinemab, first-in-class semaphorin 4D MAb, enhances combination immunotherapy

2019 ◽  
Author(s):  
Elizabeth E. Evans ◽  
Holm Bussler ◽  
Crystal Mallow ◽  
Christine Reilly ◽  
Sebold Torno ◽  
...  
Keyword(s):  
Myeloid Cells ◽  
Combination Immunotherapy ◽  
Semaphorin 4D

Abstract 1762: Shifting the tumor microenvironment with first-in-class semaphorin 4D mab for combination immunotherapy

2018 ◽  
Author(s):  
Elizabeth E. Evans ◽  
Holm Bussler ◽  
Crystal Mallow ◽  
Christine Reilly ◽  
Sebold Torno ◽  
...  
Keyword(s):  
Tumor Microenvironment ◽  
Combination Immunotherapy ◽  
Semaphorin 4D

Abstract #218: An Unusual Case of Insulin Resistance Type B and its Successful Treatment with Combination Immunotherapy

2017 ◽  
Vol 23 ◽  
pp. 38-39
Author(s):  
Sheetal Malhotra ◽  
Shanaz Sikder ◽  
Elaine Cochran ◽  
Mattingly Megan ◽  
Gorden Phillip ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Successful Treatment ◽  
Unusual Case ◽  
Combination Immunotherapy ◽  
Type B
Sign in / Sign up

Export Citation Format

Share Document